XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.3
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED) - USD ($)
$ in Thousands
Total
Impact of ASC 326 Adoption
Common Stock
Additional Paid-In Capital
Retained Earnings
Retained Earnings
Impact of ASC 326 Adoption
Accumulated Other Comprehensive Income (Loss)
Balance at the beginning of period (in shares) at Dec. 31, 2022     7,183,915        
Balance in the beginning of period at Dec. 31, 2022 $ 265,753 $ (569) $ 60,050 $ 2,088 $ 274,781 $ (569) $ (71,166)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 9,598       9,598    
Stock incentive plan 69     69      
Forfeiture of restricted shares of common stock (in shares)     (1,130)        
Issuance of shares of common stock as board compensation (in shares)     1,660        
Issuance of shares of common stock as board compensation 84   $ 84        
Repurchase of common stock (in shares)     (6,795)        
Repurchase of common stock (346)   $ (346)        
Cash dividend (574)       (574)    
Other comprehensive income (loss) 2,625           2,625
Balance at the end of period (in shares) at Mar. 31, 2023     7,177,650        
Balance at the end of period at Mar. 31, 2023 276,640   $ 59,788 2,157 283,236   (68,541)
Balance at the beginning of period (in shares) at Dec. 31, 2022     7,183,915        
Balance in the beginning of period at Dec. 31, 2022 265,753 $ (569) $ 60,050 2,088 274,781 $ (569) (71,166)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 26,587            
Other comprehensive income (loss) (6,320)            
Balance at the end of period (in shares) at Sep. 30, 2023     7,150,685        
Balance at the end of period at Sep. 30, 2023 281,951   $ 58,031 2,327 299,079   (77,486)
Balance at the beginning of period (in shares) at Mar. 31, 2023     7,177,650        
Balance in the beginning of period at Mar. 31, 2023 276,640   $ 59,788 2,157 283,236   (68,541)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 8,968       8,968    
Stock incentive plan 91     91      
Issuance of restricted shares of common stock through stock incentive plan (in shares)     9,300        
Repurchase of common stock (in shares)     (11,894)        
Repurchase of common stock (601)   $ (601)        
Cash dividend (574)       (574)    
Other comprehensive income (loss) (1,152)           (1,152)
Balance at the end of period (in shares) at Jun. 30, 2023     7,175,056        
Balance at the end of period at Jun. 30, 2023 283,372   $ 59,187 2,248 291,630   (69,693)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 8,021       8,021    
Stock incentive plan 79     79      
Forfeiture of restricted shares of common stock (in shares)     (810)        
Repurchase of common stock (in shares)     (23,561)        
Repurchase of common stock (1,156)   $ (1,156)        
Cash dividend (572)       (572)    
Other comprehensive income (loss) (7,793)           (7,793)
Balance at the end of period (in shares) at Sep. 30, 2023     7,150,685        
Balance at the end of period at Sep. 30, 2023 $ 281,951   $ 58,031 2,327 299,079   (77,486)
Balance at the beginning of period (in shares) at Dec. 31, 2023 7,091,637   7,091,637        
Balance in the beginning of period at Dec. 31, 2023 $ 303,851   $ 55,136 2,407 306,802   (60,494)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 8,188       8,188    
Stock incentive plan 78     78      
Issuance of shares of common stock as board compensation (in shares)     811        
Issuance of shares of common stock as board compensation 41   $ 41        
Repurchase of common stock (in shares)     (200,000)        
Repurchase of common stock (10,000)   $ (10,000)        
Cash dividend (638)       (638)    
Other comprehensive income (loss) (2,206)           (2,206)
Balance at the end of period (in shares) at Mar. 31, 2024     6,892,448        
Balance at the end of period at Mar. 31, 2024 $ 299,314   $ 45,177 2,485 314,352   (62,700)
Balance at the beginning of period (in shares) at Dec. 31, 2023 7,091,637   7,091,637        
Balance in the beginning of period at Dec. 31, 2023 $ 303,851   $ 55,136 2,407 306,802   (60,494)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 24,929            
Other comprehensive income (loss) $ 10,870            
Balance at the end of period (in shares) at Sep. 30, 2024 6,826,120   6,826,120        
Balance at the end of period at Sep. 30, 2024 $ 324,318   $ 41,402 2,682 329,858   (49,624)
Balance at the beginning of period (in shares) at Mar. 31, 2024     6,892,448        
Balance in the beginning of period at Mar. 31, 2024 299,314   $ 45,177 2,485 314,352   (62,700)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 7,987       7,987    
Stock incentive plan 105     105      
Issuance of restricted shares of common stock through stock incentive plan (in shares)     10,700        
Repurchase of common stock (in shares)     (16,220)        
Repurchase of common stock (764)   $ (764)        
Cash dividend (620)       (620)    
Other comprehensive income (loss) 968           968
Balance at the end of period (in shares) at Jun. 30, 2024     6,886,928        
Balance at the end of period at Jun. 30, 2024 306,990   $ 44,413 2,590 321,719   (61,732)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 8,754       8,754    
Stock incentive plan 92     92      
Forfeiture of restricted shares of common stock (in shares)     (575)        
Repurchase of common stock (in shares)     (60,233)        
Repurchase of common stock (3,011)   $ (3,011)        
Cash dividend (615)       (615)    
Other comprehensive income (loss) $ 12,108           12,108
Balance at the end of period (in shares) at Sep. 30, 2024 6,826,120   6,826,120        
Balance at the end of period at Sep. 30, 2024 $ 324,318   $ 41,402 $ 2,682 $ 329,858   $ (49,624)